As of 30 Sep 2025, 150 institutional investors reported holding 4,719,905 shares of ISHARES TR - U.S. PHARMA ETF (IHE).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 165,108 | $13,996,534 | +$9,896,075 | $84.83 | 24 |
| 2025 Q3 | 4,719,905 | $342,444,031 | -$13,869,443 | $72.56 | 150 |
| 2025 Q2 | 4,968,369 | $325,628,195 | -$8,276,835 | $65.54 | 140 |
| 2025 Q1 | 4,897,901 | $345,371,935 | -$39,000,021 | $70.56 | 151 |
| 2024 Q4 | 5,467,783 | $359,359,917 | +$8,463,665 | $65.72 | 156 |
| 2024 Q3 | 5,298,041 | $374,021,462 | -$36,539,203 | $70.61 | 144 |
| 2024 Q2 | 5,831,524 | $386,871,861 | +$20,429,427 | $66.32 | 143 |
| 2024 Q1 | 5,585,305 | $378,308,781 | +$224,982,917 | $67.90 | 140 |
| 2023 Q4 | 2,092,523 | $386,524,330 | +$264,647,538 | $185.40 | 137 |
| 2023 Q3 | 618,504 | $109,495,602 | -$4,592,717 | $176.98 | 126 |
| 2023 Q2 | 645,577 | $115,762,827 | -$10,083,284 | $179.11 | 118 |
| 2023 Q1 | 734,313 | $129,088,785 | -$4,630,135 | $175.28 | 127 |
| 2022 Q4 | 747,188 | $138,995,470 | +$9,168,861 | $186.13 | 127 |
| 2022 Q3 | 692,535 | $117,426,900 | -$7,415,939 | $169.54 | 109 |
| 2022 Q2 | 747,328 | $143,356,273 | +$33,526,994 | $191.65 | 120 |
| 2022 Q1 | 572,187 | $111,243,777 | +$8,958,655 | $194.25 | 118 |
| 2021 Q4 | 521,386 | $104,202,203 | -$3,381,738 | $199.66 | 107 |
| 2021 Q3 | 536,082 | $98,232,493 | +$981,063 | $183.14 | 107 |
| 2021 Q2 | 529,598 | $98,372,552 | +$6,457,088 | $185.74 | 99 |
| 2021 Q1 | 494,862 | $87,906,779 | -$2,280,688 | $177.66 | 99 |
| 2020 Q4 | 506,968 | $90,990,918 | +$3,797,914 | $179.44 | 98 |
| 2020 Q3 | 486,383 | $79,572,611 | -$9,004,469 | $163.53 | 92 |
| 2020 Q2 | 544,377 | $83,775,755 | +$14,643,808 | $153.87 | 89 |
| 2020 Q1 | 452,102 | $60,854,809 | -$20,553,537 | $134.58 | 92 |
| 2019 Q4 | 599,609 | $96,007,160 | -$71,298,776 | $160.11 | 91 |
| 2019 Q3 | 1,050,914 | $147,043,719 | +$43,798,392 | $139.85 | 82 |
| 2019 Q2 | 733,992 | $110,709,985 | +$8,525,948 | $150.79 | 84 |
| 2019 Q1 | 676,767 | $104,199,730 | -$235,018 | $153.97 | 90 |
| 2018 Q4 | 686,070 | $96,581,468 | -$28,851,227 | $140.76 | 94 |
| 2018 Q3 | 879,156 | $147,563,653 | -$38,842 | $167.84 | 96 |
| 2018 Q2 | 877,348 | $132,807,979 | -$9,909,076 | $151.35 | 91 |
| 2018 Q1 | 945,004 | $139,386,111 | -$139,511,090 | $147.54 | 101 |
| 2017 Q4 | 1,851,023 | $285,754,473 | -$31,401,818 | $154.38 | 107 |
| 2017 Q3 | 2,029,359 | $317,355,482 | -$32,578,466 | $156.36 | 100 |
| 2017 Q2 | 2,243,445 | $348,068,556 | -$8,951,364 | $155.13 | 93 |
| 2017 Q1 | 2,302,977 | $347,593,226 | +$60,440,664 | $150.94 | 95 |
| 2016 Q4 | 1,953,627 | $276,365,000 | +$114,945,783 | $141.42 | 92 |
| 2016 Q3 | 1,120,283 | $166,549,000 | -$45,855,195 | $149.44 | 85 |
| 2016 Q2 | 1,360,676 | $196,592,354 | -$20,154,851 | $144.40 | 87 |
| 2016 Q1 | 1,493,203 | $204,733,027 | -$99,284,833 | $136.98 | 89 |
| 2015 Q4 | 2,215,257 | $357,839,814 | +$3,571,560 | $161.69 | 103 |
| 2015 Q3 | 2,164,584 | $321,148,738 | -$24,327,846 | $148.02 | 102 |
| 2015 Q2 | 2,310,854 | $404,115,318 | -$39,781,267 | $174.82 | 119 |
| 2015 Q1 | 2,536,179 | $437,086,452 | +$86,720,586 | $172.42 | 107 |
| 2014 Q4 | 2,053,922 | $310,975,960 | +$27,141,841 | $151.40 | 101 |
| 2014 Q3 | 1,843,426 | $258,684,490 | -$10,400,827 | $140.35 | 85 |
| 2014 Q2 | 1,917,704 | $259,124,112 | -$2,844,652 | $135.11 | 87 |
| 2014 Q1 | 1,947,976 | $246,645,151 | +$26,478,475 | $126.69 | 86 |